Is HCMV a tumor promoter?

Virus Research

Volumn 157, Issue 2, 2011, Pages 193-203

  Soroceanu, Liliana ^a   Cobbs, Charles S ^a,b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glioblastoma; Human cytomegalovirus; Oncomodulation; Tumor promoter

Indexed keywords

CELL DNA; MICRORNA; TUMOR PROMOTER;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL INVASION; CELL SECRETION; CHRONIC INFLAMMATION; COLON CANCER; CYTOMEGALOVIRUS INFECTION; EPIGENETICS; EVIDENCE BASED PRACTICE; FETUS DISEASE; FIBROBLAST; GLIOBLASTOMA; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOCOMPETENCE; IMMUNOREGULATION; MITOGENICITY; MODULATION; MUTATION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; STEM CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR MICROENVIRONMENT;

ANGIOGENESIS INDUCING AGENTS; APOPTOSIS; CELL CYCLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA REPAIR; GLYCOLYSIS; HUMANS; IMMUNE EVASION; INFLAMMATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENE PROTEINS; ONCOGENIC VIRUSES; RECEPTORS, CHEMOKINE; RETINOBLASTOMA PROTEIN; TUMOR ESCAPE; TUMOR SUPPRESSOR PROTEIN P53; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 79954991007     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.10.026     Document Type: Article

References (157)

1. Ahmad A., Wang Z., Kong D., Ali R., Ali S., Banerjee S., Sarkar F.H. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-kappaB signaling pathways. Breast Cancer Res. Treat. 2010, doi:10.1007/s10549-010-0883-2.
2. Albrecht T., Deng C.Z., Abdel-Rahman S.Z., Fons M., Cinciripini P., El-Zein R.A. Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection. Environ. Mol. Mutagen. 2004, 43(3):169-178.
3. Allart S., Martin H., Detraves C., Terrasson J., Caput D., Davrinche C. Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha. J. Biol. Chem. 2002, 277(32):29063-29068.
4. Allavena P., Sica A., Garlanda C., Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 2008, 222:155-161.
5. Assanah M., Lochhead R., Ogden A., Bruce J., Goldman J., Canoll P. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J. Neurosci. 2006, 26(25):6781-6790.
6. Bakker R.A., Casarosa P., Timmerman H., Smit M.J., Leurs R. Constitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptors. J. Biol. Chem. 2004, 279(7):5152-5161.
7. Balkwill F., Charles K.A., Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7(3):211-217.
8. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444(7120):756-760.
9. Benz C., Hengel H. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance. Virus Genes 2000, 21(1-2):39-47.
10. Berasain C., Castillo J., Perugorria M.J., Latasa M.U., Prieto J., Avila M.A. Inflammation and liver cancer: new molecular links. Ann. N.Y. Acad. Sci. 2009, 1155:206-221.
11. Besold K., Wills M., Plachter B. Immune evasion proteins gpUS2 and gpUS11 of human cytomegalovirus incompletely protect infected cells from CD8 T cell recognition. Virology 2009, 391(1):5-19.
12. Blaheta R.A., Beecken W.D., Engl T., Jonas D., Oppermann E., Hundemer M., Doerr H.W., Scholz M., Cinatl J. Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness. Neoplasia 2004, 6(4):323-331.
13. Blaheta R.A., Weich E., Marian D., Bereiter-Hahn J., Jones J., Jonas D., Michaelis M., Doerr H.W., Cinatl J. Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix. Neoplasia 2006, 8(10):807-816.
14. Britt W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 2008, 325:417-470.
15. Campbell J.S., Hughes S.D., Gilbertson D.G., Palmer T.E., Holdren M.S., Haran A.C., Odell M.M., Bauer R.L., Ren H.P., Haugen H.S., Yeh M.M., Fausto N. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(9):3389-3394.
16. Castillo J.P., Frame F.M., Rogoff H.A., Pickering M.T., Yurochko A.D., Kowalik T.F. Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response. J. Virol. 2005, 79(17):11467-11475.
17. Castillo J.P., Kowalik T.F. Human cytomegalovirus immediate early proteins and cell growth control. Gene 2002, 290(1-2):19-34.
18. Chambers J.W., Maguire T.G., Alwine J.C. Glutamine metabolism is essential for human cytomegalovirus infection. J. Virol. 2010, 84(4):1867-1873.
19. Chan G., Bivins-Smith E.R., Smith M.S., Smith P.M., Yurochko A.D. Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J. Immunol. 2008, 181(1):698-711.
20. Chan G., Bivins-Smith E.R., Smith M.S., Yurochko A.D. Transcriptome analysis of NF-kappaB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes. J. Virol. 2008, 82(2):1040-1046.
21. Chan G., Bivins-Smith E.R., Smith M.S., Yurochko A.D. NF-kappaB and phosphatidylinositol 3-kinase activity mediates the HCMV-induced atypical M1/M2 polarization of monocytes. Virus Res. 2009, 144(1-2):329-333.
22. Chang W.L., Baumgarth N., Yu D., Barry P.A. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol. 2004, 78(16):8720-8731.
23. Cheeran M.C., Hu S., Ni H.T., Sheng W., Palmquist J.M., Peterson P.K., Lokensgard J.R. Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J. Neurosci. Res. 2005, 82(6):839-850.
24. Cheeran M.C., Hu S., Sheng W.S., Peterson P.K., Lokensgard J.R. CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J. Virol. 2003, 77(8):4502-4515.
25. Chen Z., Knutson E., Kurosky A., Albrecht T. Degradation of p21cip1 in cells productively infected with human cytomegalovirus. J. Virol. 2001, 75(8):3613-3625.
26. Cinatl J., Bittoova M., Margraf S., Vogel J.U., Cinatl J., Preiser W., Doerr H.W. Cytomegalovirus infection decreases expression of thrombospondin-1 and -2 in cultured human retinal glial cells: effects of antiviral agents. J. Infect. Dis. 2000, 182(3):643-651.
27. Cinatl J., Cinatl J., Vogel J.U., Kotchetkov R., Driever P.H., Kabickova H., Kornhuber B., Schwabe D., Doerr H.W. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res. 1998, 58(2):367-372.
28. Cinatl J., Cinatl J., Vogel J.U., Rabenau H., Kornhuber B., Doerr H.W. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 1996, 39(4):259-269.
29. Cinatl J., Kotchetkov R., Scholz M., Cinatl J., Vogel J.U., Driever P.H., Doerr H.W. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am. J. Pathol. 1999, 155(1):285-292.
30. Cinatl J., Vogel J.U., Kotchetkov R., Scholz M., Doerr H.W. Proinflammatory potential of cytomegalovirus infection. Specific inhibition of cytomegalovirus immediate-early expression in combination with antioxidants as a novel treatment strategy. Intervirology 1999, 42(5-6):419-424.
31. Cinatl J., Vogel J.U., Kotchetkov R., Wilhelm Doerr H. Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. FEMS Microbiol. Rev. 2004, 28(1):59-77.
32. Cobbs C.S., Brenman J.E., Aldape K.D., Bredt D.S., Israel M.A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1995, 55(4):727-730.
33. Cobbs C.S., Harkins L., Samanta M., Gillespie G.Y., Bharara S., King P.H., Nabors L.B., Cobbs C.G., Britt W.J. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002, 62(12):3347-3350.
34. Cobbs C.S., Soroceanu L., Denham S., Zhang W., Britt W.J., Pieper R., Kraus M.H. Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness. J. Neurooncol. 2007, 85(3):271-280.
35. Cobbs C.S., Soroceanu L., Denham S., Zhang W., Kraus M.H. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res. 2008, 68(3):724-730.
36. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009, 30(7):1073-1081.
37. DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., Thompson C.B. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(49):19345-19350.
38. Demaria S., Pikarsky E., Karin M., Coussens L.M., Chen Y.C., El-Omar E.M., Trinchieri G., Dubinett S.M., Mao J.T., Szabo E., Krieg A., Weiner G.J., Fox B.A., Coukos G., Wang E., Abraham R.T., Carbone M., Lotze M.T. Cancer and inflammation: promise for biologic therapy. J. Immunother. 2010, 33(4):335-351.
39. Desbaillets I., Tada M., de Tribolet N., Diserens A.C., Hamou M.F., Van Meir E.G. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int. J. Cancer 1994, 58(2):240-247.
40. Ding Q., Stewart J., Olman M.A., Klobe M.R., Gladson C.L. The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged. J. Biol. Chem. 2003, 278(41):39882-39891.
41. Dumortier J., Streblow D.N., Moses A.V., Jacobs J.M., Kreklywich C.N., Camp D., Smith R.D., Orloff S.L., Nelson J.A. Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing. J. Virol. 2008, 82(13):6524-6535.
42. Erlandsson A., Brannvall K., Gustafsdottir S., Westermark B., Forsberg-Nilsson K. Autocrine/paracrine platelet-derived growth factor regulates proliferation of neural progenitor cells. Cancer Res. 2006, 66(16):8042-8048.
43. Esseghir S., Todd S.K., Hunt T., Poulsom R., Plaza-Menacho I., Reis-Filho J.S., Isacke C.M. A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer. Cancer Res. 2007, 67(24):11732-11741.
44. Fantini M.C., Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr. Drug Targets 2008, 9(5):375-380.
45. Farrell H.E., Vally H., Lynch D.M., Fleming P., Shellam G.R., Scalzo A.A., Davis-Poynter N.J. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997, 386(6624):510-514.
46. Fortunato E.A., Dell'Aquila M.L., Spector D.H. Specific chromosome 1 breaks induced by human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(2):853-858.
47. Fortunato E.A., Spector D.H. Viral induction of site-specific chromosome damage. Rev. Med. Virol. 2003, 13(1):21-37.
48. Fredericks D.N., Relman D.A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 1996, 9(1):18-33.
49. Gao J.L., Murphy P.M. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J. Biol. Chem. 1994, 269(46):28539-28542.
50. Geder L., Sanford E.J., Rohner T.J., Rapp F. Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells. Cancer Treat. Rep. 1977, 61(2):139-146.
51. Gomez G.G., Kruse C.A. Mechanisms of malignant glioma immune resistance and sources of immunosuppression. Gene Ther. Mol. Biol. 2006, 10(A):133-146.
52. Goodrum F.D., Jordan C.T., High K., Shenk T. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(25):16255-16260.
53. Gottwein E., Cullen B.R. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 2008, 3(6):375-387.
54. Greijer A.E., Verschuuren E.A., Dekkers C.A., Adriaanse H.M., van der Bij W., The T.H., Middeldorp J.M. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients. J. Infect. Dis. 2001, 184(3):247-255.
55. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., Kagnoff M.F., Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118(3):285-296.
56. Grey F., Meyers H., White E.A., Spector D.H., Nelson J. A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog. 2007, 3(11):e163.
57. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140(6):883-899.
58. Hagemeier C., Walker S., Caswell R., Kouzarides T., Sinclair J. The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J. Virol. 1992, 66(7):4452-4456.
59. Hara A., Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol. 2004, 108(1):43-48.
60. Harkins L., Volk A.L., Samanta M., Mikolaenko I., Britt W.J., Bland K.I., Cobbs C.S. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002, 360(9345):1557-1563.
61. Hayashi M.L., Blankenship C., Shenk T. Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(6):2692-2696.
62. Hengel H., Brune W., Koszinowski U.H. Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist. Trends Microbiol. 1998, 6(5):190-197.
63. Holland E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2001, 2(2):120-129.
64. Hsu S.C., Volpert O.V., Steck P.A., Mikkelsen T., Polverini P.J., Rao S., Chou P., Bouck N.P. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res. 1996, 56(24):5684-5691.
65. Hsu W.M., Chen S.S., Peng C.H., Chen C.F., Ko Y.C., Tsai D.C., Chou C.K., Ho L.L., Chiou S.H., Liu J.H. Elevated nitric oxide level in aqueous humor of AIDS patients with cytomegalovirus retinitis. Ophthalmologica 2003, 217(4):298-301.
66. Hume A.J., Finkel J.S., Kamil J.P., Coen D.M., Culbertson M.R., Kalejta R.F. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 2008, 320(5877):797-799.
67. Humphries W., Wei J., Sampson J.H., Heimberger A.B. The role of tregs in glioma-mediated immunosuppression: potential target for intervention. Neurosurg. Clin. North Am. 2010, 21(1):125-137.
68. Hussain S.F., Yang D., Suki D., Aldape K., Grimm E., Heimberger A.B. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-Oncology 2006, 8(3):261-279.
69. Ibanez C.E., Schrier R., Ghazal P., Wiley C., Nelson J.A. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 1991, 65(12):6581-6588.
70. Isaacson M.K., Feire A.L., Compton T. Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J. Virol. 2007, 81(12):6241-6247.
71. Jackson E.L., Garcia-Verdugo J.M., Gil-Perotin S., Roy M., Quinones-Hinojosa A., VandenBerg S., Alvarez-Buylla A. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 2006, 51(2):187-199.
72. Jarvis M.A., Nelson J.A. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr. Opin. Microbiol. 2002, 5(4):403-407.
73. Jarvis M.A., Nelson J.A. Mechanisms of human cytomegalovirus persistence and latency. Front Biosci. 2002, 7:d1575-d1582.
74. Jault F.M., Jault J.M., Ruchti F., Fortunato E.A., Clark C., Corbeil J., Richman D.D., Spector D.H. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 1995, 69(11):6697-6704.
75. Jia W., Jackson-Cook C., Graf M.R. Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma+vaccination model. J. Neuroimmunol. 2010, 223(1-2):20-30.
76. Johnson R.A., Huong S.M., Huang E.S. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J. Virol. 2000, 74(3):1158-1167.
77. Johnson R.A., Wang X., Ma X.L., Huong S.M., Huang E.S. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol. 2001, 75(13):6022-6032.
78. Kalejta R.F., Bechtel J.T., Shenk T. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol. Cell Biol. 2003, 23(6):1885-1895.
79. Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb. Perspect. Biol. 2009, 1(5):a000141.
80. Kim R., Emi M., Tanabe K. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology 2006, 119(2):254-264.
81. Kim R., Emi M., Tanabe K., Arihiro K. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res. 2006, 66(11):5527-5536.
82. Komohara Y., Ohnishi K., Kuratsu J., Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 2008, 216(1):15-24.
83. Kovacs A., Weber M.L., Burns L.J., Jacob H.S., Vercellotti G.M. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am. J. Pathol. 1996, 149(5):1531-1539.
84. Lau S.K., Chen Y.Y., Chen W.G., Diamond D.J., Mamelak A.N., Zaia J.A., Weiss L.M. Lack of association of cytomegalovirus with human brain tumors. Mod. Pathol. 2005, 18(6):838-843.
85. Lazennec G., Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med. 2010, 16(3):133-144.
86. Loenen W.A., Bruggeman C.A., Wiertz E.J. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin. Immunol. 2001, 13(1):41-49.
87. Luo M.H., Hannemann H., Kulkarni A.S., Schwartz P.H., O'Dowd J.M., Fortunato E.A. Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J. Virol. 2010, 84(7):3528-3541.
88. Luo M.H., Rosenke K., Czornak K., Fortunato E.A. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 2007, 81(4):1934-1950.
89. Luo M.H., Schwartz P.H., Fortunato E.A. Neonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infection. J. Virol. 2008, 82(20):9994-10007.
90. Matsukage S., Kosugi I., Kawasaski H., Miura K., Kitani H., Tsutsui Y. Mouse embryonic stem cells are not susceptible to cytomegalovirus but acquire susceptibility during differentiation. Birth Defects Res. A: Clin. Mol. Teratol. 2006, 76(2):115-125.
91. Maussang D., Langemeijer E., Fitzsimons C.P., Stigter-van Walsum M., Dijkman R., Borg M.K., Slinger E., Schreiber A., Michel D., Tensen C.P., van Dongen G.A., Leurs R., Smit M.J. The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res. 2009, 69(7):2861-2869.
92. Maussang D., Verzijl D., van Walsum M., Leurs R., Holl J., Pleskoff O., Michel D., van Dongen G.A., Smit M.J. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(35):13068-13073.
93. Michaelis M., Doerr H.W., Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 2009, 11(1):1-9.
94. Michelson S. Human cytomegalovirus escape from immune detection. Intervirology 1999, 42(5-6):301-307.
95. Mitchell D., Xie W., Schmittling R., Learn C., Friedman A., McLendon R.E., Sampson J.H. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-Oncology 2008, 10(1):10-18.
96. Munger J., Bajad S.U., Coller H.A., Shenk T., Rabinowitz J.D. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006, 2(12):e132.
97. Nachmani D., Stern-Ginossar N., Sarid R., Mandelboim O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 2009, 5(4):376-385.
98. Nachtwey J., Spencer J.V. HCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-kappaB. Viral Immunol. 2008, 21(4):477-482.
99. Nelson J.A. Small RNAs and large DNA viruses. N. Engl. J. Med. 2007, 357(25):2630-2632.
100. Ng W.H., Wan G.Q., Peng Z.N., Too H.P. Glial cell-line derived neurotrophic factor (GDNF) family of ligands confer chemoresistance in a ligand-specific fashion in malignant gliomas. J. Clin. Neurosci. 2009, 16(3):427-436.
101. Nystad M., Fagerheim T., Brox V., Fortunato E.A., Nilssen O. Human cytomegalovirus (HCMV) and hearing impairment: infection of fibroblast cells with HCMV induces chromosome breaks at 1q23.3, between loci DFNA7 and DFNA49 - both involved in dominantly inherited, sensorineural, hearing impairment. Mutat. Res. 2008, 637(1-2):56-65.
102. Odeberg J., Wolmer N., Falci S., Westgren M., Seiger A., Soderberg-Naucler C. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J. Virol. 2006, 80(18):8929-8939.
103. Oh J.W., Drabik K., Kutsch O., Choi C., Tousson A., Benveniste E.N. CXC chemokine receptor 4 expression and function in human astroglioma cells. J. Immunol. 2001, 166(4):2695-2704.
104. Pari G.S., Netski D., St Jeor S., McCarthy D., Smith J., Georgio D., von Hofe E. Generation of a nude mouse tumor model for in vivo replication of human cytomegalovirus. J. Infect. Dis. 1998, 177(3):523-528.
105. Parney I.F., Farr-Jones M.A., Chang L.J., Petruk K.C. Human glioma immunobiology in vitro: implications for immunogene therapy. Neurosurgery 2000, 46(5):1169-1177. discussion 1177-8.
106. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., van Dyk L.F., Ho C.K., Shuman S., Chien M., Russo J.J., Ju J., Randall G., Lindenbach B.D., Rice C.M., Simon V., Ho D.D., Zavolan M., Tuschl T. Identification of microRNAs of the herpesvirus family. Nat. Methods 2005, 2(4):269-276.
107. Poland S.D., Costello P., Dekaban G.A., Rice G.P. Cytomegalovirus in the brain: in vitro infection of human brain-derived cells. J. Infect. Dis. 1990, 162(6):1252-1262.
108. Poltermann S., Schlehofer B., Steindorf K., Schnitzler P., Geletneky K., Schlehofer J.R. Lack of association of herpesviruses with brain tumors. J. Neurovirol. 2006, 12(2):90-99.
109. Reeves M.B., Davies A.A., McSharry B.P., Wilkinson G.W., Sinclair J.H. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 2007, 316(5829):1345-1348.
110. Reinhardt B., Mertens T., Mayr-Beyrle U., Frank H., Luske A., Schierling K., Waltenberger J. HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor. Cardiovasc. Res. 2005, 67(1):151-160.
111. Reinke P., Prosch S., Kern F., Volk H.D. Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. Transpl. Infect. Dis. 1999, 1(3):157-164.
112. Riegler S., Hebart H., Einsele H., Brossart P., Jahn G., Sinzger C. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 2000, 81(Pt 2):393-399.
113. Roorda B.D., ter Elst A., Kamps W.A., de Bont E.S. Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit. Rev. Oncol. Hematol. 2009, 69(3):187-198.
114. Rossi M.L., Hughes J.T., Esiri M.M., Coakham H.B., Brownell D.B. Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol. 1987, 74(3):269-277.
115. Samanta M., Harkins L., Klemm K., Britt W.J., Cobbs C.S. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J. Urol. 2003, 170(3):998-1002.
116. Sanford E.J., Geder L., Laychock A., Rohner T.J., Rapp F. Evidence for the association of cytomegalovirus with carcinoma of the prostate. J. Urol. 1977, 118(5):789-792.
117. Scheurer M.E.-Z.R., Bondy M., Harkins L., Cobbs C. Re: " Lack of association of herpesviruses with brain tumors" J. Neurovirol. 2007, 13:85-87.
118. Scheurer M.E., Bondy M.L., Aldape K.D., Albrecht T., El-Zein R. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol. 2008, 116(1):79-86.
119. Scholz M., Blaheta R.A., Wittig B., Cinatl J., Vogel J.U., Doerr H.W., Cinatl J. Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta1alpha5 integrin (VLA-5). Tissue Antigens 2000, 55(5):412-421.
120. Scholz M., Doerr H.W., Cinatl J. Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol. 2003, 11(4):171-178.
121. Shen Y., Zhu H., Shenk T. Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate " hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(7):3341-3345.
122. Shih A.H., Holland E.C. Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett. 2006, 232(2):139-147.
123. Shinmura Y., Aiba-Masago S., Kosugi I., Li R.Y., Baba S., Tsutsui Y. Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirus. Am. J. Pathol. 1997, 151(5):1331-1340.
124. Shono T., Tofilon P.J., Bruner J.M., Owolabi O., Lang F.F. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res. 2001, 61(11):4375-4381.
125. Siew V.K., Duh C.Y., Wang S.K. Human cytomegalovirus UL76 induces chromosome aberrations. J. Biomed. Sci. 2009, 16:107.
126. Sinclair J., Sissons P. Latent and persistent infections of monocytes and macrophages. Intervirology 1996, 39(5-6):293-301.
127. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63(18):5821-5828.
128. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401.
129. Sinzger C., Plachter B., Grefte A., The T.H., Jahn G. Tissue macrophages are infected by human cytomegalovirus in vivo. J. Infect. Dis. 1996, 173(1):240-245.
130. Slinger E., Maussang D., Schreiber A., Siderius M., Rahbar A., Fraile-Ramos A., Lira S.A., Soderberg-Naucler C., Smit M.J. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci. Signal. 2010, 3(133). p. ra58.
131. Smirnov S.V., Harbacheuski R., Lewis-Antes A., Zhu H., Rameshwar P., Kotenko S.V. Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential. Virology 2007, 360(1):6-16.
132. Soderberg-Naucler C. HCMV microinfections in inflammatory diseases and cancer. J. Clin. Virol. 2008, 41(3):218-223.
133. Soderberg-Naucler C., Fish K.N., Nelson J.A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997, 91(1):119-126.
134. Soroceanu L., Akhavan A., Cobbs C.S. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 2008, 455(7211):391-395.
135. Stern-Ginossar N., Elefant N., Zimmermann A., Wolf D.G., Saleh N., Biton M., Horwitz E., Prokocimer Z., Prichard M., Hahn G., Goldman-Wohl D., Greenfield C., Yagel S., Hengel H., Altuvia Y., Margalit H., Mandelboim O. Host immune system gene targeting by a viral miRNA. Science 2007, 317(5836):376-381.
136. Straat K., Liu C., Rahbar A., Zhu Q., Liu L., Wolmer-Solberg N., Lou F., Liu Z., Shen J., Jia J., Kyo S., Bjorkholm M., Sjoberg J., Soderberg-Naucler C., Xu D. Activation of telomerase by human cytomegalovirus. J. Natl. Cancer Inst. 2009, 101(7):488-497.
137. Streblow D.N., Kreklywich C.N., Andoh T., Moses A.V., Dumortier J., Smith P.P., Defilippis V., Fruh K., Nelson J.A., Orloff S.L. The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Am. J. Transplant. 2008, 8(2):277-287.
138. Streblow D.N., Soderberg-Naucler C., Vieira J., Smith P., Wakabayashi E., Ruchti F., Mattison K., Altschuler Y., Nelson J.A. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999, 99(5):511-520.
139. Suzuki S., Kameoka M., Nakaya T., Kimura T., Nishi N., Hirai K., Ikuta K. Superoxide generation by monocytes following infection with human cytomegalovirus. Immunopharmacology 1997, 37(2-3):185-190.
140. Sylwester A.W., Mitchell B.L., Edgar J.B., Taormina C., Pelte C., Ruchti F., Sleath P.R., Grabstein K.H., Hosken N.A., Kern F., Nelson J.A., Picker L.J. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005, 202(5):673-685.
141. Tanabe K., Matsushima-Nishiwaki R., Yamaguchi S., Iida H., Dohi S., Kozawa O. Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells. J. Neuroinflammation 2010, 7:16. doi:10.1186/1742-2094-7-16.
142. Taylor-Wiedeman J., Sissons P., Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 1994, 68(3):1597-1604.
143. Tenan M., Fulci G., Albertoni M., Diserens A.C., Hamou M.F., El Atifi-Borel M., Feige J.J., Pepper M.S., Van Meir E.G. Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells. J. Exp. Med. 2000, 191(10):1789-1798.
144. Tsujii M., Kawano S., DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(7):3336-3340.
145. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998, 93(5):705-716.
146. Wang J.C. Good cells gone bad: the cellular origins of cancer. Trends Mol. Med. 2010, 16(3):145-151.
147. Wang Y., Liu Y., Zhang Y., Peng L., Ma J., Tang Z., Gao W., Zhu Z., Yao Z. The role of the CD95, CD38 and TGFbeta1 during active human cytomegalovirus infection in liver transplantation. Cytokine 2006, 35(3-4):193-199.
148. Warburg O. Klin. Wochenschr Berl. 1925, 4:534-536.
149. Wiertz E., Hill A., Tortorella D., Ploegh H. Cytomegaloviruses use multiple mechanisms to elude the host immune response. Immunol. Lett. 1997, 57(1-3):213-216.
150. Williams C., Shattuck-Brandt R.L., DuBois R.N. The role of COX-2 in intestinal cancer. Ann. N.Y. Acad. Sci. 1999, 889:72-83.
151. Yong R.L., Shinojima N., Fueyo J., Gumin J., Vecil G.G., Marini F.C., Bogler O., Andreeff M., Lang F.F. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res. 2009, 69(23):8932-8940.
152. Young L.S., Rickinson A.B. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 2004, 4(10):757-768.
153. Yurochko A.D., Kowalik T.F., Huong S.M., Huang E.S. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol. 1995, 69(9):5391-5400.
154. Zhu H., Cong J.P., Mamtora G., Gingeras T., Shenk T. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(24):14470-14475.
155. Zhu H., Cong J.P., Yu D., Bresnahan W.A., Shenk T.E. From the cover: inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(6):3932-3937.
156. Zhu H., Shen Y., Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 1995, 69(12):7960-7970.
157. Zou J.P., Morford L.A., Chougnet C., Dix A.R., Brooks A.G., Torres N., Shuman J.D., Coligan J.E., Brooks W.H., Roszman T.L., Shearer G.M. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers. J. Immunol. 1999, 162(8):4882-4892.